THU0152 SARCOPENIA IS ASSOCIATED WITH PERSISTENT DISEASE ACTIVITY DURING FOLLOW-UP OF RHEUMATOID ARTHRITIS. (June 2019)
- Record Type:
- Journal Article
- Title:
- THU0152 SARCOPENIA IS ASSOCIATED WITH PERSISTENT DISEASE ACTIVITY DURING FOLLOW-UP OF RHEUMATOID ARTHRITIS. (June 2019)
- Main Title:
- THU0152 SARCOPENIA IS ASSOCIATED WITH PERSISTENT DISEASE ACTIVITY DURING FOLLOW-UP OF RHEUMATOID ARTHRITIS
- Authors:
- Park, Dong-Jin
Kang, Ji-Hyoun
Xu, Haimuzi
Lee, Kyung-Eun
Lee, Shin-Seok - Abstract:
- Abstract : Objectives: This study investigated the prevalence and impact of sarcopenia on clinical outcomes during follow-up in patients with rheumatoid arthritis (RA). Methods: We enrolled 294 RA patients from a single tertiary center. Data were collected at the time of enrollment and annually thereafter for 3 consecutive years. Sarcopenia was assessed by bioelectrical impedance analysis and defined as a relative skeletal mass index (RSMI) < 5.14 kg/m 2 in women and < 7.40 kg/m 2 in men. Univariate and multivariate analyses were performed to identify the association between sarcopenia and clinical outcome. Results: Of the 294 RA patients, 8.2% had sarcopenia at the time of enrollment. Patients with sarcopenia were more likely to be older ( P =0.001), male ( P =0.001), and smokers ( P =0.001), and to have a higher body fat mass ( P =0.034) and body fat percentage ( P =0.039), and a lower basal metabolic rate ( P =0.013), than non-sarcopenic patients. Biologic agents were more commonly prescribed to sarcopenic patients than to non-sarcopenic patients ( P =0.048). The sarcopenic patients had higher Physician Global Assessment (PGA) ( P =0.015), higher mean and delta tender joints ( P =0.007), higher mean and delta swollen joints ( P =0.007), and higher mean DAS28-ESR ( P =0.014) and DAS28-CRP ( P =0.020) scores than the non-sarcopenic patients. In the multivariate analysis, sarcopenia was significantly associated with male gender (OR = 0.112, 95% CI: 0.041–0.304, P <0.001),Abstract : Objectives: This study investigated the prevalence and impact of sarcopenia on clinical outcomes during follow-up in patients with rheumatoid arthritis (RA). Methods: We enrolled 294 RA patients from a single tertiary center. Data were collected at the time of enrollment and annually thereafter for 3 consecutive years. Sarcopenia was assessed by bioelectrical impedance analysis and defined as a relative skeletal mass index (RSMI) < 5.14 kg/m 2 in women and < 7.40 kg/m 2 in men. Univariate and multivariate analyses were performed to identify the association between sarcopenia and clinical outcome. Results: Of the 294 RA patients, 8.2% had sarcopenia at the time of enrollment. Patients with sarcopenia were more likely to be older ( P =0.001), male ( P =0.001), and smokers ( P =0.001), and to have a higher body fat mass ( P =0.034) and body fat percentage ( P =0.039), and a lower basal metabolic rate ( P =0.013), than non-sarcopenic patients. Biologic agents were more commonly prescribed to sarcopenic patients than to non-sarcopenic patients ( P =0.048). The sarcopenic patients had higher Physician Global Assessment (PGA) ( P =0.015), higher mean and delta tender joints ( P =0.007), higher mean and delta swollen joints ( P =0.007), and higher mean DAS28-ESR ( P =0.014) and DAS28-CRP ( P =0.020) scores than the non-sarcopenic patients. In the multivariate analysis, sarcopenia was significantly associated with male gender (OR = 0.112, 95% CI: 0.041–0.304, P <0.001), mean PGA score (OR = 1.680, 95% CI: 1.067–2.646, P =0.025), and mean DAS28-ESR score (OR = 4.477, 95% CI: 1.661–12.067, P =0.003). Conclusion: Sarcopenia at baseline was an independent predictor of disease activity during follow-up in Korean patients with RA. Our results provide a rationale for lifestyle interventions designed to maintain normal weight in RA patients and thus help control disease activity. Disclosure of Interests: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 78(2019)Supplement 2
- Issue Display:
- Volume 78, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 78
- Issue:
- 2
- Issue Sort Value:
- 2019-0078-0002-0000
- Page Start:
- 349
- Page End:
- 349
- Publication Date:
- 2019-06
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2019-eular.3412 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19926.xml